ArticleBMC microbiology2025
Quorum quenching by endophytic Bacillus cereus AL1: a lactonase-based anti-virulence strategy against Pseudomonas aeruginosa.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antibiotic Resistance and the Return to a Pre-Antibiotic Era: A Critical Narrative Review of a Global Catastrophe.Biomedicines · 2026Review
- GC-MS profiling and antivirulence potential of limonene-rich Citrus medica cv. 'Rugosa' essential oil: in vitro and in silico evaluations.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPseudomonas aeruginosa infections are often challenging to treat due to multiple drug resistance, besides the development of biofilms and a plethora of virulence factors regulated by quorum sensing. Quorum-quenching enzymes, such as N-acyl homoserine lactonases, represent a promising anti-virulence strategy by disrupting this signaling mechanism without exerting selective pressure, leading to resistance. This study aimed to screen endophyte and epiphyte isolates for lactonase activity and evaluate their potential to inhibit virulence in Pseudomonas aeruginosa.
resultsFifty-two bacterial isolates (42 endophyte and 10 epiphyte) were isolated from ten plants. The aiiA gene encoding lactonase enzyme was detected in 11 endophytes and one epiphyte isolate, among which nine showed complete degradation (100%) of the quorum sensing signal molecule N-hexanoyl-L-homoserine lactone. The partially purified lactonase enzyme from the endophyte Bacillus cereus AL1 isolate exhibited significant anti-virulence activity, reducing biofilm formation, swarming motility, and pyocyanin production against Pseudomonas aeruginosa PAO1 and clinical Pseudomonas aeruginosa isolates. Sequence alignment of the Bacillus cereus AL1 lactonase protein revealed close similarity to the homologous lactonase from Bacillus cereus. The quorum quenching activity of the partially purified lactonase AL1 provided protection in a Galleria mellonella infection model.
conclusionThe study highlights the potential of Bacillus cereus AL1 lactonase as an effective anti-virulence agent against Pseudomonas aeruginosa without the pressure for resistance development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.